Skip to main content
Equibles

Glen French

CEO

Pulmonx Corp (LUNG)

Equibles does not estimate personal net worth.

Get an email with a short summary when Pulmonx Corp publishes a filing, an earnings call transcript or a press release.

Get LUNG alerts

About Glen French

Glen French is recorded as CEO at Pulmonx Corp (LUNG). Pulmonx Corp reported in an 8-K filed October 27, 2025 that Glen French was appointed President and Chief Executive Officer, effective October 27, 2025. Glen French has spoken on 9 earnings calls across 1 company, most recently for Pulmonx Corp on April 29, 2026. Pulmonx Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pulmonx Corp includes Glendon E. French (CEO and Board Member), Glendon French (CEO and Board Member), Steven S. Williamson (CEO and Board Member) and 5 others.

“Pulmonx Corporation ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the reappointment of Glen French as President and Chief Executive Officer, effective immediately”
Pulmonx Corp Form 8-K, filed October 27, 2025 · Read the filing

Glen French on recent calls

“Here with me is Derek Sung, our Chief Operating Officer and Chief Financial Officer. Pulmonix delivered total worldwide revenue of $20.6 million in the first quarter of 2026.”
CEO, Pulmonx Corp Q1 FY2026 Earnings Call ·
“There are a number of pharmaceuticals that are out there that are being used for the treatment of patients with COPD. And some of them are targeting smooth muscles.”
CEO, Pulmonx Corp Q1 FY2023 Earnings Call ·
“Good afternoon, everyone, and welcome to our fourth quarter and full year 2022 earnings call. Here with me is Derrick Sung, our Chief Financial Officer. I'll begin with a few highlights to contextualize our fourth quarter and full year 2022 results before turning to our outlook and strategic priorities for 2023.”
CEO, Pulmonx Corp Q4 FY2022 Earnings Call ·
“I think it’s reasonable to characterize it as a cautious number. I think it’s very important to us that we set out things that we don’t like to have calls like this one, where we are reporting on things that we didn’t deliver in the way that we said that we would.”
CEO, Pulmonx Corp Q3 FY2022 Earnings Call ·
“Here with me is Derrick Sung, our Chief Financial Officer. In the second quarter, we generated worldwide sales of $14 million, representing our highest quarterly revenue to date.”
CEO, Pulmonx Corp Q2 FY2022 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pulmonx Corp

Recent activity